195 related articles for article (PubMed ID: 29991720)
1. The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification.
Gilmour J; Assi SA; Noailles L; Lichtinger M; Obier N; Bonifer C
Sci Rep; 2018 Jul; 8(1):10410. PubMed ID: 29991720
[TBL] [Abstract][Full Text] [Related]
2. Developmental-stage-dependent transcriptional response to leukaemic oncogene expression.
Regha K; Assi SA; Tsoulaki O; Gilmour J; Lacaud G; Bonifer C
Nat Commun; 2015 May; 6():7203. PubMed ID: 26018585
[TBL] [Abstract][Full Text] [Related]
3. Conversion of adult endothelium to immunocompetent haematopoietic stem cells.
Lis R; Karrasch CC; Poulos MG; Kunar B; Redmond D; Duran JGB; Badwe CR; Schachterle W; Ginsberg M; Xiang J; Tabrizi AR; Shido K; Rosenwaks Z; Elemento O; Speck NA; Butler JM; Scandura JM; Rafii S
Nature; 2017 May; 545(7655):439-445. PubMed ID: 28514438
[TBL] [Abstract][Full Text] [Related]
4. Efficient hemogenic endothelial cell specification by RUNX1 is dependent on baseline chromatin accessibility of RUNX1-regulated TGFβ target genes.
Howell ED; Yzaguirre AD; Gao P; Lis R; He B; Lakadamyali M; Rafii S; Tan K; Speck NA
Genes Dev; 2021 Nov; 35(21-22):1475-1489. PubMed ID: 34675061
[TBL] [Abstract][Full Text] [Related]
5. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.
Pearson S; Sroczynska P; Lacaud G; Kouskoff V
Development; 2008 Apr; 135(8):1525-35. PubMed ID: 18339678
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis.
Lichtinger M; Ingram R; Hannah R; Müller D; Clarke D; Assi SA; Lie-A-Ling M; Noailles L; Vijayabaskar MS; Wu M; Tenen DG; Westhead DR; Kouskoff V; Lacaud G; Göttgens B; Bonifer C
EMBO J; 2012 Nov; 31(22):4318-33. PubMed ID: 23064151
[TBL] [Abstract][Full Text] [Related]
7. Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis.
Bergiers I; Andrews T; Vargel Bölükbaşı Ö; Buness A; Janosz E; Lopez-Anguita N; Ganter K; Kosim K; Celen C; Itır Perçin G; Collier P; Baying B; Benes V; Hemberg M; Lancrin C
Elife; 2018 Mar; 7():. PubMed ID: 29555020
[TBL] [Abstract][Full Text] [Related]
8. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
[TBL] [Abstract][Full Text] [Related]
9. A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers.
Marsman J; Thomas A; Osato M; O'Sullivan JM; Horsfield JA
Sci Rep; 2017 Oct; 7(1):13347. PubMed ID: 29042628
[TBL] [Abstract][Full Text] [Related]
10. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
Stanulovic VS; Cauchy P; Assi SA; Hoogenkamp M
Nucleic Acids Res; 2017 Sep; 45(17):9874-9888. PubMed ID: 28973433
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
Webber BR; Iacovino M; Choi SH; Tolar J; Kyba M; Blazar BR
Blood; 2013 Oct; 122(17):2978-86. PubMed ID: 24030384
[TBL] [Abstract][Full Text] [Related]
12. Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.
Lie-A-Ling M; Marinopoulou E; Lilly AJ; Challinor M; Patel R; Lancrin C; Kouskoff V; Lacaud G
Development; 2018 Mar; 145(5):. PubMed ID: 29530939
[TBL] [Abstract][Full Text] [Related]
13. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
14. Runx1 is sufficient for blood cell formation from non-hemogenic endothelial cells
Yzaguirre AD; Howell ED; Li Y; Liu Z; Speck NA
Development; 2018 Jan; 145(2):. PubMed ID: 29361566
[TBL] [Abstract][Full Text] [Related]
15. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter.
Chen MJ; Yokomizo T; Zeigler BM; Dzierzak E; Speck NA
Nature; 2009 Feb; 457(7231):887-91. PubMed ID: 19129762
[TBL] [Abstract][Full Text] [Related]
16. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis.
Pimkin M; Kossenkov AV; Mishra T; Morrissey CS; Wu W; Keller CA; Blobel GA; Lee D; Beer MA; Hardison RC; Weiss MJ
Genome Res; 2014 Dec; 24(12):1932-44. PubMed ID: 25319996
[TBL] [Abstract][Full Text] [Related]
17. Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.
Liang OD; So EY; Egan PC; Goldberg LR; Aliotta JM; Wu KQ; Dubielecka PM; Ventetuolo CE; Reginato AM; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2017 Nov; 113(13):1560-1573. PubMed ID: 29016733
[TBL] [Abstract][Full Text] [Related]
18. NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes.
Zang C; Luyten A; Chen J; Liu XS; Shivdasani RA
Sci Rep; 2016 Jul; 6():30255. PubMed ID: 27457419
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Runx1 in the down-regulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells.
Hirai H; Samokhvalov IM; Fujimoto T; Nishikawa S; Imanishi J; Nishikawa S
Blood; 2005 Sep; 106(6):1948-55. PubMed ID: 15928041
[TBL] [Abstract][Full Text] [Related]
20. Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1.
Majumder A; Syed KM; Joseph S; Scambler PJ; Dutta D
J Biol Chem; 2015 May; 290(21):13053-63. PubMed ID: 25847244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
